| scholarly article | Q13442814 |
| P50 | author | Urs Albrecht | Q30380489 |
| James S. Sutcliffe | Q37651326 | ||
| P2093 | author name string | A L Beaudet | |
| G Eichele | |||
| D Armstrong | |||
| B M Cattanach | |||
| C V Beechey | |||
| P2860 | cites work | UBE3A/E6-AP mutations cause Angelman syndrome | Q24311799 |
| Cloning and tissue distribution of subunits C, D, and E of the human vacuolar H(+)-ATPase | Q24321516 | ||
| Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade | Q29620459 | ||
| Uniparental paternal disomy in Angelman's syndrome | Q33244469 | ||
| Is Angelman syndrome an alternate result of del(15)(q11q13)? | Q34187549 | ||
| Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. | Q34314269 | ||
| The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region | Q34428426 | ||
| Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion | Q34461093 | ||
| Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. | Q36660357 | ||
| Imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D15S225E). | Q36731355 | ||
| Angelman syndrome | Q40923007 | ||
| Puppet-like syndrome of Angelman: a pathologic and neurochemical study | Q41930929 | ||
| Promoter-specific imprinting of the human insulin-like growth factor-II gene | Q46095293 | ||
| De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome | Q48056435 | ||
| Angelman's syndrome: a neuropathological study | Q48556801 | ||
| A candidate model for Angelman syndrome in the mouse | Q48678528 | ||
| Maternal origin of 15q11-13 deletions in Angelman syndrome suggests a role for genomic imprinting. | Q51169317 | ||
| Parental imprinting of the mouse insulin-like growth factor II gene. | Q55052428 | ||
| Cytogenetic and molecular analysis in Angelman syndrome | Q72219024 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Purkinje cell | Q1570272 |
| Angelman syndrome | Q535364 | ||
| P304 | page(s) | 75-78 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons | |
| P478 | volume | 17 |
| Q24683678 | 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders |
| Q48224906 | 15q11.2 Duplication Encompassing Only the UBE3A Gene Is Associated with Developmental Delay and Neuropsychiatric Phenotypes |
| Q50329951 | A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders |
| Q36858585 | A Drosophila model for Angelman syndrome |
| Q34383677 | A Neurodevelopmental Survey of Angelman Syndrome With Genotype-Phenotype Correlations |
| Q28079929 | A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons. |
| Q34603155 | A fine balance: Regulation of hippocampal Arc/Arg3.1 transcription, translation and degradation in a rat model of normal cognitive aging |
| Q24532087 | A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation |
| Q35155998 | A new deletion refines the boundaries of the murine Prader-Willi syndrome imprinting center |
| Q22009166 | A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region |
| Q80359545 | A targeted deletion upstream of Snrpn does not result in an imprinting defect |
| Q41159863 | Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome |
| Q36719062 | Allan Award Introduction: Arthur L. Beaudet |
| Q37699565 | Allelic specificity of Ube3a expression in the mouse brain during postnatal development |
| Q36353107 | Alterations in intrinsic membrane properties and the axon initial segment in a mouse model of Angelman syndrome |
| Q27321157 | Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. |
| Q38681920 | Alzheimer's Disease and ncRNAs. |
| Q35958258 | An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A. |
| Q33791880 | An inside job: how endosomal Na(+)/H(+) exchangers link to autism and neurological disease |
| Q37140791 | An overview of nuclear receptor coregulators involved in cerebellar development |
| Q33985870 | Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors |
| Q47638614 | Analysis of imprinting in mice with uniparental duplication of proximal chromosomes 7 and 15 by use of a custom oligonucleotide microarray |
| Q34128475 | Angelman Syndrome, a Genomic Imprinting Disorder of the Brain |
| Q35811797 | Angelman Syndrome. |
| Q51890699 | Angelman syndrome due to a novel splicing mutation of the UBE3A gene. |
| Q98463747 | Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment |
| Q86066086 | Angelman syndrome in adulthood |
| Q63644832 | Angelman syndrome: Mutations influence features in early childhood |
| Q24678174 | Angelman syndrome: a review of the clinical and genetic aspects |
| Q35544005 | Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms |
| Q24612484 | Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes |
| Q38216017 | Angelman syndrome: review of clinical and molecular aspects |
| Q74837223 | Animal models for dysmorphology |
| Q31147226 | Antisense transcripts with FANTOM2 clone set and their implications for gene regulation |
| Q48415183 | Atp10a, a gene adjacent to the PWS/AS gene cluster, is not imprinted in mouse and is insensitive to the PWS-IC. |
| Q30440078 | Behavioral deficits in an Angelman syndrome model: effects of genetic background and age. |
| Q28247810 | Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy |
| Q44985714 | Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein. |
| Q41836063 | Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. |
| Q50345135 | Case report: Angelman syndrome in an individual with a small SMC(15) and paternal uniparental disomy: a case report with reference to the assessment of cognitive functioning and autistic symptomatology |
| Q35881586 | Cerebellar associative sensory learning defects in five mouse autism models |
| Q30601827 | Cerebellar plasticity and motor learning deficits in a copy-number variation mouse model of autism |
| Q58376444 | Characterization of Human hect Domain Family Members and Their Interaction with UbcH5 and UbcH7 |
| Q91757431 | Circadian biology and sleep in monogenic neurological disorders and its potential application in drug discovery |
| Q37743131 | Clinical and genetic aspects of Angelman syndrome |
| Q45893474 | Comparison of two types of non-adherent plate for neuronal differentiation of mouse embryonic stem cells |
| Q33887777 | Competition--a common motif for the imprinting mechanism? |
| Q48262483 | Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome |
| Q26995242 | Dendritic spine dysgenesis in autism related disorders |
| Q47771802 | Dense linkage disequilibrium mapping in the 15q11-q13 maternal expression domain yields evidence for association in autism |
| Q37712028 | Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. |
| Q80103789 | Discordant phenotypes in first cousins with UBE3A frameshift mutation |
| Q35170630 | Disease susceptibility genes for autism |
| Q28288697 | Dissociation of IGF2 and H19 imprinting in human brain |
| Q36266495 | Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model |
| Q52130756 | Distinct multi-joint control strategies in spastic diplegia associated with prematurity or Angelman syndrome. |
| Q31800343 | Does genomic imprinting contribute to valproic acid teratogenicity? |
| Q64259104 | Down-Regulation of miRNA-708 Promotes Aberrant Calcium Signaling by Targeting Neuronatin in a Mouse Model of Angelman Syndrome |
| Q34580149 | Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism. |
| Q34446311 | Dynamic developmental regulation of the large non-coding RNA associated with the mouse 7C imprinted chromosomal region. |
| Q28291338 | E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box |
| Q38148981 | E6AP in the brain: one protein, dual function, multiple diseases |
| Q36760286 | E6AP/UBE3A ubiquitin ligase harbors two E2~ubiquitin binding sites |
| Q39191796 | Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a |
| Q64040161 | Electrophysiological Phenotype in Angelman Syndrome Differs Between Genotypes |
| Q36862650 | Epigenetic alteration of imprinted genes during neural differentiation of germline-derived pluripotent stem cells. |
| Q38087264 | Epigenetic factors and autism spectrum disorders |
| Q22251432 | Etiologies underlying sex differences in Autism Spectrum Disorders |
| Q81453927 | Expression and assay of HECT domain ligases |
| Q37092589 | Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase |
| Q57990814 | Familial interstitial 570 kbp deletion of theUBE3Agene region causing Angelman syndrome but not Prader-Willi syndrome |
| Q46569544 | Forging our understanding of lncRNAs in the brain |
| Q26781685 | From UBE3A to Angelman syndrome: a substrate perspective |
| Q27931992 | Functional domains of the Rsp5 ubiquitin-protein ligase. |
| Q33697249 | Gender influences monoallelic expression of ATP10A in human brain |
| Q28593439 | Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction |
| Q37961799 | Genetic and epigenetic dysregulation of imprinted genes in the brain |
| Q39023653 | Genetic control of postnatal human brain growth |
| Q50983366 | Genetic engineering cures mice of neurological deficits: prospects for treating Angelman syndrome. |
| Q37098748 | Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. |
| Q33655104 | Genetics of Angelman syndrome |
| Q34329756 | Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation |
| Q35158316 | Genome-wide mapping of imprinted differentially methylated regions by DNA methylation profiling of human placentas from triploidies |
| Q33721384 | Genomic imprinting and chromatin insulation in Beckwith-Wiedemann syndrome |
| Q35575191 | Genomic imprinting and the social brain |
| Q34699894 | Genomic imprinting effects on brain development and function |
| Q37715275 | Genomic imprinting in development, growth, behavior and stem cells |
| Q30494000 | Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a |
| Q35250186 | Genomic imprinting: a chromatin connection |
| Q33603375 | Genomic imprinting: concept and clinical consequences |
| Q33541538 | Genomic imprinting: implications for human disease |
| Q30444132 | HECT E3s and human disease |
| Q35649390 | Hematopoietic reconstitution with androgenetic and gynogenetic stem cells |
| Q89964995 | Hereditary Spastic Paraplegia and Intellectual Disability: Clinicogenetic Lessons From a Family Suggesting a Dual Genetics Diagnosis |
| Q34779403 | Highly parallel SNP genotyping reveals high-resolution landscape of mono-allelic Ube3a expression associated with locus-wide antisense transcription |
| Q35195947 | Histone H3 trimethylation at lysine 36 is associated with constitutive and facultative heterochromatin |
| Q36210923 | Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes. |
| Q35793734 | Identification of the Meg1/Grb10 imprinted gene on mouse proximal chromosome 11, a candidate for the Silver-Russell syndrome gene |
| Q34161356 | Impact of induced pluripotent stem cells on the study of central nervous system disease |
| Q52144715 | Impaired Neurite Contact Guidance in Ubiquitin Ligase E3a (Ube3a)-Deficient Hippocampal Neurons on Nanostructured Substrates. |
| Q28486135 | Impairment of TrkB-PSD-95 signaling in Angelman syndrome |
| Q33852775 | Imprinted genes as potential genetic and epigenetic toxicologic targets |
| Q51975646 | Imprinted genes, cognition and behaviour. |
| Q37278948 | Imprinted noncoding RNAs |
| Q37543706 | Imprinting and extraembryonic tissues-mom takes control |
| Q47739224 | Imprinting in Angelman and Prader-Willi syndromes |
| Q48013064 | Imprinting in Prader-Willi and Angelman syndromes |
| Q52187194 | Imprinting mechanisms in mammals. |
| Q34026945 | Imprinting: focusing on the center |
| Q38776890 | In Vitro Corticogenesis from Embryonic Stem Cells Recapitulates the In Vivo Epigenetic Control of Imprinted Gene Expression. |
| Q47682400 | In silico modeling of the cryptic E2∼ubiquitin-binding site of E6-associated protein (E6AP)/UBE3A reveals the mechanism of polyubiquitin chain assembly |
| Q37080106 | In vivo and in vitro differentiation of uniparental embryonic stem cells into hematopoietic and neural cell types |
| Q30514133 | Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. |
| Q34140440 | Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes |
| Q33964940 | Insights into synaptic function from mouse models of human cognitive disorders |
| Q24628031 | Integrated YAC contig map of the Prader-Willi/Angelman region on chromosome 15q11-q13 with average STS spacing of 35 kb |
| Q48360900 | Introduction of Arthur L. Beaudet, Harland Sanders Award recipient |
| Q24534306 | Isoform-specific imprinting of the human PEG1/MEST gene |
| Q34385408 | Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers |
| Q50309632 | Longitudinal follow-up of autism spectrum features and sensory behaviors in Angelman syndrome by deletion class |
| Q48164862 | Markers associated with neuron-specific Ube3a imprinting during neuronal differentiation of mouse embryonic stem cells. |
| Q36128318 | Maternal Ube3a Loss Disrupts Sleep Homeostasis But Leaves Circadian Rhythmicity Largely Intact. |
| Q24531844 | Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans |
| Q36025486 | Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. |
| Q48906893 | Maternal repression of the human GRB10 gene in the developing central nervous system; evaluation of the role for GRB10 in Silver-Russell syndrome. |
| Q91940591 | Mechanisms underlying the EEG biomarker in Dup15q syndrome |
| Q47553724 | Mechanistic insights into the genetics of affective psychosis from Prader-Willi syndrome |
| Q74105881 | Meeting report; "Molecular neurobiological mechanisms in schizophrenia: seeking a synthesis," April 11-14, 1999 |
| Q33926084 | Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome |
| Q39003471 | Model mice for 15q11-13 duplication syndrome exhibit late-onset obesity and altered lipid metabolism. |
| Q28081179 | Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development |
| Q50501125 | Modeling human epilepsies in mice. |
| Q36455952 | Modes of imprinted gene action in learning disability |
| Q36006585 | Molecular and Clinical Aspects of Angelman Syndrome. |
| Q36846974 | Molecular basis of genetic neuropsychiatric disorders |
| Q84404767 | Molecular characterization of porcine NECD, SNRPN and UBE3A genes and imprinting status in the skeletal muscle of neonate pigs |
| Q34517515 | Molecular genetics and animal models in autistic disorder |
| Q34388784 | Molecular mechanism of angelman syndrome in two large families involves an imprinting mutation |
| Q33309940 | Monoallelic expression of multiple genes in the CNS. |
| Q36716971 | Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links. |
| Q35905042 | Mouse genetic approaches to investigating calcium/calmodulin-dependent protein kinase II function in plasticity and cognition. |
| Q54623728 | Mouse imprinting defect mutations that model Angelman syndrome. |
| Q35172443 | Mouse models for neurological disease |
| Q38248435 | Mutation Update for UBE3A variants in Angelman syndrome |
| Q34385742 | Mutation analysis of UBE3A in Angelman syndrome patients |
| Q48354837 | Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. |
| Q54066632 | Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. |
| Q88100139 | Myoclonus in Angelman syndrome |
| Q39695230 | Neocortical development as an evolutionary platform for intragenomic conflict |
| Q50344374 | Neurodevelopmental disease: A molecular tightrope. |
| Q35033286 | Neurological disease: UPS stops delivering! |
| Q34956275 | Neuronal chromatin dynamics of imprinting in development and disease |
| Q46165200 | Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome. |
| Q37445958 | New Perspectives on Genomic Imprinting, an Essential and Multifaceted Mode of Epigenetic Control in the Developing and Adult Brain |
| Q37145622 | No evidence for parental imprinting of mouse 22q11 gene orthologs |
| Q36872209 | Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease |
| Q46134005 | Novel paternally expressed intergenic transcripts at the mouse Prader-Willi/Angelman Syndrome locus |
| Q35832545 | Of mothers and myelin: Aberrant myelination phenotypes in mouse model of Angelman syndrome are dependent on maternal and dietary influences |
| Q28361223 | Parent-specific complementary patterns of histone H3 lysine 9 and H3 lysine 4 methylation at the Prader-Willi syndrome imprinting center |
| Q42605402 | Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome |
| Q37010745 | Persistent neuronal Ube3a expression in the suprachiasmatic nucleus of Angelman syndrome model mice |
| Q36992786 | Potential therapeutic approaches for Angelman syndrome |
| Q28200133 | Prader-Willi and Angelman syndromes: sister imprinted disorders |
| Q50305492 | Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype |
| Q47933557 | Predominant maternal expression of the mouse Atp10c in hippocampus and olfactory bulb |
| Q34611594 | Primary function analysis of human mental retardation related gene CRBN. |
| Q36675332 | Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain |
| Q38781012 | Quantitative Measurement of Communication Ability in Children with Angelman Syndrome |
| Q35881887 | Quantitative and functional interrogation of parent-of-origin allelic expression biases in the brain |
| Q40540300 | Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. |
| Q33859404 | Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome |
| Q48294933 | Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. |
| Q36010566 | Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors |
| Q47785030 | Reversal of reduced parvalbumin neurons in hippocampus and amygdala of Angelman syndrome model mice by chronic treatment of fluoxetine |
| Q34372681 | Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease |
| Q34694722 | SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis? |
| Q40744184 | Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital |
| Q92069505 | Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse |
| Q24534447 | Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which Is highly expressed in brain |
| Q37000934 | Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation |
| Q36164754 | Spatial and temporal silencing of the human maternal UBE3A gene |
| Q34386278 | Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis |
| Q44765720 | The -4 phenylalanine is required for substrate ubiquitination catalyzed by HECT ubiquitin ligases |
| Q33744301 | The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. |
| Q37198437 | The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation. |
| Q47364339 | The Autism Protein Ube3A/E6AP Remodels Neuronal Dendritic Arborization via Caspase-Dependent Microtubule Destabilization. |
| Q64078884 | The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions |
| Q37090067 | The Drosophila homologue of the Angelman syndrome ubiquitin ligase regulates the formation of terminal dendritic branches |
| Q37308111 | The Drosophila melanogaster homolog of UBE3A is not imprinted in neurons |
| Q24594577 | The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13 |
| Q24521626 | The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase |
| Q24291232 | The human aminophospholipid-transporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression |
| Q36088917 | The influence of non-coding RNAs on allele-specific gene expression in mammals |
| Q34550513 | The mouse Murr1 gene is imprinted in the adult brain, presumably due to transcriptional interference by the antisense-oriented U2af1-rs1 gene. |
| Q24671994 | The odyssey of MeCP2 and parental imprinting |
| Q27021312 | The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders |
| Q37733830 | The role of imprinted genes in mediating susceptibility to neuropsychiatric disorders. |
| Q37155452 | The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins |
| Q35967532 | The ubiquitin system: pathogenesis of human diseases and drug targeting |
| Q33540242 | The ubiquitin-proteasome pathway and pathogenesis of human diseases |
| Q24292709 | The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction |
| Q34070860 | Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome |
| Q45299733 | Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease. |
| Q24610399 | Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons |
| Q35493127 | Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells |
| Q35154104 | Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. |
| Q33389173 | Transcriptome-wide identification of novel imprinted genes in neonatal mouse brain |
| Q36325687 | Transcriptomic changes in brain development |
| Q89747418 | Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome |
| Q60046933 | UBE3A and Its Link With Autism |
| Q51115136 | UbFluor: A Fluorescent Thioester to Monitor HECT E3 Ligase Catalysis. |
| Q35143079 | Ube3a imprinting impairs circadian robustness in Angelman syndrome models |
| Q37340937 | Ube3a is required for experience-dependent maturation of the neocortex. |
| Q34019149 | Ubiquitin-mediated proteolysis in learning and memory |
| Q36101992 | Understanding the pathogenesis of Angelman syndrome through animal models |
| Q34488451 | Upregulation of imprinted genes in mice: an insight into the intensity of gene expression and the evolution of genomic imprinting |
| Q36214949 | Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene |
| Q33883551 | Variable imprinting of the heterotrimeric G protein G(s) alpha-subunit within different segments of the nephron |
| Q47973503 | Zim1, a maternally expressed mouse Kruppel-type zinc-finger gene located in proximal chromosome 7. |
| Q41378038 | mTORC1-S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice |
Search more.